Ritamezin Tablet 2.5/1000 mg

Adult dose

This medication is administered twice daily with meals. 1. If not previously treated with Metformin, the initial dose is 1 tablet of this medication 2.5/500 mg twice daily, with a possible increase to 1 tablet of 2.5/1000 mg twice daily. 2. In cases where blood sugar control is difficult with Metformin monotherapy, Linagliptin 2.5 mg twice daily and the existing dose of Metformin should be administered. 3. In combination therapy with Linagliptin and Metformin.

This medication may cause a very rare side effect known as lactic acidosis, which can be more dangerous in cases of rapidly deteriorating renal function or issues with the heart or lungs. Patients with allergies to the active ingredients or components of this drug, those with type 1 diabetes, lactic acidosis, diabetic ketoacidosis, severe renal impairment, liver dysfunction, acute alcohol intoxication, as well as those who are pregnant or breastfeeding should not use this medication. Caution is required when using this drug in combination with other blood sugar-lowering medications as there is a risk of hypoglycemia, especially when used with insulin or sulfonylureas, as dosage adjustments may be necessary. Patients with weakened renal function or elderly patients should regularly undergo renal function tests and should not use this drug if renal function drops below a certain standard. Patients with poor cardiac function should also exercise caution when using this medication, and symptoms such as acute pancreatitis or bullous pemphigoid skin conditions may occur, necessitating immediate consultation with a doctor if they arise. This medication can lower vitamin B12 levels, so it is advisable to monitor vitamin B12 status through blood tests during long-term use. If iodine contrast agents used in radiological examinations are administered, this medication should be discontinued for a period before and after the test, and it should also be suspended around the time of surgery. Women who are pregnant or planning to become pregnant should preferably avoid using this medication, and it should also be avoided during breastfeeding. Use in children under 10 years of age and adolescents aged 10 to 17 is not recommended as safety and efficacy have not been adequately established. Overdose poses a significant risk of lactic acidosis, so if any abnormal symptoms appear, medical attention should be sought immediately, and blood dialysis may be necessary. This medication should be stored out of reach of children, away from moisture, and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis,

Mild side effects

• Pharyngitis
• hypersensitivity
• angioedema
• hypoglycemia
• taste disorder
• cough
• appetite decrease
• diarrhea
• constipation
• nausea

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is also advisable to store the medication at room temperature, avoiding places that are too hot or too cold, ideally between 1°C and 30°C.

Appearance

Bright pink, double-convex, oval film-coated tablet

Package unit

30 tablets/bottle, 60 tablets/bottle